RxDoctor Payments Data

Steven Giuseffi, MD

Orthopaedic Surgery · Rapid City, SDNPI 1871759522

Payments from drug & device makers

What this record shows

Stryker accounts for 71.5% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2021 at $1,574 and has fallen 65.6% since, to $541 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in SD, where the typical reported total is $3,305.

$3,104in general payments, 2019–2025

Across 38 payments — averaging $81.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Smith+Nephew$812
  • Vericel Corporation$43
  • Sioux Surgical Inc$30

What the payments were for

  • Travel & lodging$1,43546%
  • Food & beverage$1,66954%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker26$2,218
Smith+Nephew9$812
Vericel Corporation2$43
Sioux Surgical Inc1$30

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,104 in reported general payments places this provider in the 45th percentile of 92 orthopaedic surgery providers in South Dakota.

See all orthopaedic surgery providers in South Dakota

Medicare billing

Part B allowed, 2024
$226,751
Medicare patients
352
Services billed
5,695

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam27$138
Amoxicillin25$40

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Rapid City

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →